Blood-stage Malaria Vaccine Candidate RH5.1/Matrix-M in Healthy Tanzanian Adults and Children; an Open-Label, Non-Randomised, First-in-human, Single-Centre, Phase 1b Trial
Sarah E. Silk,Wilmina F. Kalinga,Jo Salkeld,Ivanny M. Mtaka,Saumu Ahmed,Florence Milando,Ababacar Diouf,Caroline K. Bundi,Neema Balige,Omar Hassan,Catherine G. Mkindi,Thabit Athumani,Stella Rwezaula,Sarah Mswata,Nasoro S. Lilolime,Beatus Simon,Hania Msami,Mohamed,Damiano M. David,Latipha Mohammed,Gloria Nyaulingo,Bakari Mwalimu,Omary Juma,Tunu G. Mwamlima, Ibrahim A. Sasamalo,Rose P. Mkumbange,Janeth J. Kamage,Jordan R. Barrett,Lloyd D. W. King,Mimi M. Hou,David Pulido,Cecilia Carnrot,Alison M. Lawrie, Rachel E. Cowan,Fay L. Nugent,Rachel Roberts,Jee-Sun Cho,Carole A. Long,Carolyn M. Nielsen,Kazutoyo Miura,Simon J. Draper,Ally Olotu,Angela M. Minassian LANCET INFECTIOUS DISEASES（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper